MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer.
Han J, Choi YL, Kim H, Choi JY, Lee SK, Lee JE, Choi JS, Park S, Choi JS, Kim YD, Nam SJ, Nam BH, Kwon MJ, Shin YK.
Han J, et al. Among authors: shin yk.
Breast Cancer Res Treat. 2017 Jul;164(1):41-56. doi: 10.1007/s10549-017-4234-4. Epub 2017 Apr 13.
Breast Cancer Res Treat. 2017.
PMID: 28409241
Free PMC article.